Hashizume K - Search Results

1

micro-Crystallin as an intracellular 3,5,3'-triiodothyronine holder in vivo.

Suzuki S, Suzuki N, Mori J, Oshima A, Usami S, Hashizume K. Suzuki S, et al. Among authors: hashizume k. Mol Endocrinol. 2007 Apr;21(4):885-94. doi: 10.1210/me.2006-0403. Epub 2007 Jan 30. Mol Endocrinol. 2007. PMID: 17264173

2

Cell-specific expression of NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine-binding protein (p38CTBP).

Suzuki S, Mori J, Kobayashi M, Inagaki T, Inaba H, Komatsu A, Yamashita K, Takeda T, Miyamoto T, Ichikawa K, Hashizume K. Suzuki S, et al. Among authors: hashizume k. Eur J Endocrinol. 2003 Feb;148(2):259-68. doi: 10.1530/eje.0.1480259. Eur J Endocrinol. 2003. PMID: 12590647

3

mu-crystallin, a NADPH-dependent T(3)-binding protein in cytosol.

Suzuki S, Mori J, Hashizume K. Suzuki S, et al. Among authors: hashizume k. Trends Endocrinol Metab. 2007 Sep;18(7):286-9. doi: 10.1016/j.tem.2007.07.002. Epub 2007 Aug 9. Trends Endocrinol Metab. 2007. PMID: 17692531 Review.

4

Expression of thyroid hormone receptor alpha in 3T3-L1 adipocytes; triiodothyronine increases the expression of lipogenic enzyme and triglyceride accumulation.

Jiang W, Miyamoto T, Kakizawa T, Sakuma T, Nishio S, Takeda T, Suzuki S, Hashizume K. Jiang W, et al. Among authors: hashizume k. J Endocrinol. 2004 Aug;182(2):295-302. doi: 10.1677/joe.0.1820295. J Endocrinol. 2004. PMID: 15283690

5

{mu}-Crystallin, new candidate protein in endotoxin-induced uveitis.

Imai H, Ohta K, Yoshida A, Suzuki S, Hashizume K, Usami S, Kikuchi T. Imai H, et al. Among authors: hashizume k. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3554-9. doi: 10.1167/iovs.09-3728. Invest Ophthalmol Vis Sci. 2010. PMID: 20570996

6

Nicotinamide adenine dinucleotide phosphate-dependent cytosolic T(3) binding protein as a regulator for T(3)-mediated transactivation.

Mori J, Suzuki S, Kobayashi M, Inagaki T, Komatsu A, Takeda T, Miyamoto T, Ichikawa K, Hashizume K. Mori J, et al. Among authors: hashizume k. Endocrinology. 2002 Apr;143(4):1538-44. doi: 10.1210/endo.143.4.8736. Endocrinology. 2002. PMID: 11897713

7

Beneficial effects of pioglitazone on cholangiohepatitis induced by bile duct carcinoma.

Suzuki S, Mori J, Yamazaki M, Sato A, Hosoda W, Hashizume K. Suzuki S, et al. Among authors: hashizume k. Intern Med. 2007;46(20):1723-7. doi: 10.2169/internalmedicine.46.0312. Epub 2007 Oct 15. Intern Med. 2007. PMID: 17938528 Free article.

8

Do PPARgamma Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor?

Suzuki S, Hashizume K. Suzuki S, et al. Among authors: hashizume k. PPAR Res. 2008;2008:587401. doi: 10.1155/2008/587401. PPAR Res. 2008. PMID: 18615198 Free PMC article.

9

A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.

Takeda T, Yamazaki M, Minemura K, Imai Y, Inaba H, Suzuki S, Miyamoto T, Ichikawa K, Kakizawa T, Mori J, DeGroot LJ, Hashizume K. Takeda T, et al. Among authors: hashizume k. Cancer Gene Ther. 2002 Oct;9(10):864-74. doi: 10.1038/sj.cgt.7700511. Cancer Gene Ther. 2002. PMID: 12224028

10

A kindred with Cockayne syndrome caused by multiple splicing variants of the CSA gene.

Komatsu A, Suzuki S, Inagaki T, Yamashita K, Hashizume K. Komatsu A, et al. Among authors: hashizume k. Am J Med Genet A. 2004 Jul 1;128A(1):67-71. doi: 10.1002/ajmg.a.30087. Am J Med Genet A. 2004. PMID: 15211661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

980 results

Search Page